Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Phosphoglycerate mutase 1 pseudogene 9 (PGAM1P9) is a human pseudogene, meaning it is a genomic DNA sequence similar to the functional Phosphoglycerate mutase 1 gene but does not encode an active protein product and is not known to have a biological function. It is annotated as a pseudogene in human genomic databases and does not directly participate in metabolic or signaling pathways. PGAM1P9's annotation as a pseudogene clearly distinguishes it from the protein-coding PGAM1, which is a glycolytic enzyme and has established biological and therapeutic relevance. No evidence exists suggesting PGAM1P9 serves as a therapeutic target, encodes a functional protein, or is involved in disease processes. Pseudogenes can sometimes influence gene regulation, but there is currently no evidence or reports indicating any such function for PGAM1P9. External database identifiers for PGAM1P9 include HGNC: 42456, NCBI Gene: 100420681, Ensembl: ENSG00000249255.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Phosphoglycerate mutase 1 pseudogene 9 (PGAM1P9).